About
Technology
Issues
FAQ
Links
Official Page
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
